Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,148) with videos related to
Page
of 115
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2010
2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacy
Ramzi F Sweis, Julianne A Hunt, Florida Kallashi, et al.
Plos One
|
September 21, 2016
Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials
Valeria Ricotti, Matthew R B Evans, Christopher D J Sinclair, et al.
JCI Insight
|
April 13, 2021
Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
Connar Sj Westgate, Hannah F Botfield, Zerin Alimajstorovic, et al.
Metabolites
|
April 28, 2023
Amino Acid Profiles in Older Adults with Frailty: Secondary Analysis from MetaboFrail and BIOSPHERE Studies
Riccardo Calvani, Anna Picca, Leocadio Rodriguez-Mañas, et al.
Cephalalgia : an International Journal of Headache
|
September 4, 2023
Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension
Susan P Mollan, Clare L Fraser, Kathleen B Digre, et al.
Communications Biology
|
January 3, 2024
Multiple reaction monitoring assays for large-scale quantitation of proteins from 20 mouse organs and tissues
Sarah A Michaud, Helena Pětrošová, Nicholas J Sinclair, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 16, 2018
Idiopathic intracranial hypertension: consensus guidelines on management
Susan P Mollan, Brendan Davies, Nick C Silver, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2003
p38 Inhibitors: piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones
Julianne A Hunt, Florida Kallashi, Rowena D Ruzek, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 14, 2009
Disubstituted pyrimidines as Lck inhibitors
Julianne A Hunt, Richard T Beresis, Joung L Goulet, et al.
Aging Clinical and Experimental Research
|
February 2, 2017
The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods
Francesco Landi, Matteo Cesari, Riccardo Calvani, et al.
Page
of 115
Search research articles
Search
Showing results (1091-1100 of 1,148) with videos related to
Sort By:
Page
of 115
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2010
2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacy
Ramzi F Sweis, Julianne A Hunt, Florida Kallashi, et al.
Plos One
|
September 21, 2016
Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials
Valeria Ricotti, Matthew R B Evans, Christopher D J Sinclair, et al.
JCI Insight
|
April 13, 2021
Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
Connar Sj Westgate, Hannah F Botfield, Zerin Alimajstorovic, et al.
Metabolites
|
April 28, 2023
Amino Acid Profiles in Older Adults with Frailty: Secondary Analysis from MetaboFrail and BIOSPHERE Studies
Riccardo Calvani, Anna Picca, Leocadio Rodriguez-Mañas, et al.
Cephalalgia : an International Journal of Headache
|
September 4, 2023
Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension
Susan P Mollan, Clare L Fraser, Kathleen B Digre, et al.
Communications Biology
|
January 3, 2024
Multiple reaction monitoring assays for large-scale quantitation of proteins from 20 mouse organs and tissues
Sarah A Michaud, Helena Pětrošová, Nicholas J Sinclair, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 16, 2018
Idiopathic intracranial hypertension: consensus guidelines on management
Susan P Mollan, Brendan Davies, Nick C Silver, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2003
p38 Inhibitors: piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones
Julianne A Hunt, Florida Kallashi, Rowena D Ruzek, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 14, 2009
Disubstituted pyrimidines as Lck inhibitors
Julianne A Hunt, Richard T Beresis, Joung L Goulet, et al.
Aging Clinical and Experimental Research
|
February 2, 2017
The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods
Francesco Landi, Matteo Cesari, Riccardo Calvani, et al.
Page
of 115